Venture capital firm based in London, UK
InvenireX revolutionizes lab testing with AI and programmable DNA - poised to change the game in early disease detection and beyond with recent funding secured from top investors. Read more
Exciting UK spin-out Mesenbio secures £1.4m in funding to develop ground-breaking arthritis treatment, offering hope to half a million sufferers with its unique stem cell therapy that reduces inflammation and regenerates damaged tissue. Read more
SaaS | 33.3% |
Biotech | 33.3% |
Healthtech | 33.3% |